Vaccine-induced autoimmunity

Journal of Autoimmunity

Volumn 9, Issue 6, 1996, Pages 699-703

  Cohen, Arnon Dov ^b   Shoenfeld, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HLA B27 ANTIGEN; RECOMBINANT VACCINE; VACCINE;

AUTOIMMUNITY; ETIOLOGY; GUILLAIN BARRE SYNDROME; HEPATITIS B; HUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VACCINATION;

EID: 0030462910     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0091     Document Type: Review

References (62)

1. 1. Lilic D., Ghosh S.K. 1994. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 344: 1292-1293
2. 2. Biasi D., Carletto A., Caramaschi P., Frigo A., Pacor M.L., Bezzi D., Bambara L.M. 1994. Rheumatological manifestations following hmepatitis B vaccination. A report of 2 clinical cases. Recenti. Prog. Med. 85: 438-440
3. 3. Gross K, Combe C, Kruger K., Schattenkirchner M. 1995. Arthritis after hepatitis B vaccination. Scand. J. Rheumatol. 24: 50-52.
4. 4. Hachull E., Houvenagel E., Mingui A., Vincent G., Laine A. 1990. Reactive arthritis after hepatitis B vaccination. J. Rheumatol. 17: 1250-1251.
5. 5. Rogerson S.J., Nye F.J. 1990. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ 301: 345.
6. 6. Nieminen U., Peltola H., Syrjala M.T., Makipernaa A., Kekomaki R. 1993. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Pediatr. 82: 267-270.
7. 7. Peltola H, Heinonen O.P., Valle M., Paunio M., Virtanen M., Karanko V., Canteli K. 1994. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. New Eng. J. Med. 331: 1397-1402.
8. 8. Meyboom R.H.B., Fucik H., Edwards I.R. 1995. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 345: 1638.
9. 9. Tudela P., Marti S., Bonal J. 1992. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 62: 236-237.
10. 10. Swamy H.S., Anisya V., Nandi S.S., Kaliaperumal V.G. 1991. Neurological complication due to Semple-type antirabies vaccine. Clinical and therapeutic aspects. J. Assoc. Physicians India 39: 667-669.
11. 11. Topaloglu H., Berker M., Kansu T., Saatci U., Renda Y. 1992. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet 339: 178-179.
12. 12. Ubol S., Hemachudha T., Whitaker J.N., Griffin D.E. 1990. Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera. J. Neuroimmunol. 26: 107-111.
13. 13. Herroelen L., De Keyser J., Ebinger G. 1991. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine Lancet 338: 1174-1175.
14. 14. Biron P., Montpetit P., Infante-Rivard C., Lery L. 1988. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch. Intern. Med. 148: 2685.
15. 15. Beghi E., Kurland L.T., Mulder D.W., Wiederholt W.C. 1985. Guillain-Barre syndrome. Clinicoepidemilogic features and effect of influenza vaccine. Arch. Neurol. 42: 1053-107.
16. 16. Boe E., Nyland H. 1980. Guillain Barre syndrome after vaccination with human diploid cell rabies vaccine. Scand. J. Infect. Dis. 12: 231-232.
17. 17. Hurwitz E.S., Sconberger L.B., Nelson D.B., Holman R.C. 1981. Guillain Barre syndrome and the 1978-1979 influenza vaccine. N. Engl. J. Med. 304: 1557-1561.
18. 18. Schonberger L.B., Bregman D.J., Sullivan Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., Eddins D.L., Bryan J.A. 1979. Guillain Barre syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am. J. Epidemiol. 110: 105-123.
19. 19. Schonberger L.B., Hurwitz E.S., Katona P., Holman R.C., Bregman D.J. 1981. Guillain Barre syndrome: its epidemiology and associations with influenza vaccination. Ann. Neurol. 9 Suppl: 31-38.
20. 20. Uhari M., Rantala H., Niemela M. 1989. Cluster of childhood Guillain-Barre cases after an oral poliovaccine campaign. Lancet 2: 440-441.
21. 21. Hassan W., Oldham R. 1994. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ 309: 94.
22. 22. Cohen A.D., Shoenfeld Y. 1995. The viral-autoimmunity relationship. Viral Immunology 1995 8: 1-9.
23. 23. Schattner A., Rager Zisman B. 1990. Virus induced autoimmunity. Rev. Infect. Dis. 12: 204-222.
24. 24. Shoenfeld Y. and Isenberg D. eds. 1989. The mosaic of autoimmunity. Elsevier, Oxford.
25. 25. Albani S., Roudier J. 1992. Molecular basis for the association between HLA DR4 and rheumatoid arthritis. From the shared epitope hypothesis to a peptidic model of rheumatoid arthritis. Clin. Biochem. 25: 209-212.
26. 26. Alcover A., Molano J., Renart J., Gil Aguado A., Nieto A., Avila J. 1984. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus. Arthritis Rheum. 27: 922-928.
27. 27. Andre Schwartz J., Datta S.K., Shoenfeld Y., Isenberg D.A., Stollar B.D., Schwartz R.S. 1984. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin. Immunopathol. 31: 261-271.
28. 28. Anderson J.I., Carlquist J.F., Hammond E.H. 1982. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet 2: 1123-1127.
29. 29. Atkinson M.A., Maclaren N.K. 1994. The pathogenesis of insulin dependent diabetes mellitus. N. Engl. J. Med. 24: 1428-1436.
30. 30. Bao S., King N.J., Dos-Remedios J. 1992. CG Flavivirus induces HLA antigen on human myoblasts: a model of autoimmune myositis? Muscle Nerve 15: 1271-1277.
31. 31. Campbell I.L., Harrison L.C., Ashcroft R.G., Jack I. 1988. Retrovirus infection enhances expression of class I HLA proteins on human beta cell and rat RINm5F cell. Diabetes 37: 362-365.
32. 32. Fong S., Tsoukas C.D., Frincke L.A., Lawrance S.K., Holbrook T.L., Vaughan J.H., Carson D.A. 1981. Age-associated changes in Epstein-Barr virus-induced human lymphocyte autoantibody responses. J. Immunol. 126: 910-914.
33. 33. Fujinami R.S., Oldstone M.B., Wroblewska Z., Frankel M.E., Koprowski H. 1983. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc. Natl. Acad. Sci. USA 80: 2346-2350.
34. 34. Fox R.I., Luppi M., Pisa P., Kang H.I. 1992. Potential role of EBV in Sjogren's syndrome and rheumatoid arthritis. J. Rheumatol. 19 Suppl. 32: 18-24.
35. 35. Gerli R., Rambotti P., Spinozzi F., Bertotto A., Chiodini V., Solinas P., Gemini I., Davis S. 1986. Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy. Am. Heart J. 112: 350-355.
36. 36. Haspel M.V., Onodera T., Prabhakar B.S., Horita M., Suzuki H., Notkins A.L. 1983. Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science 220: 304-306.
37. 37. Haspel M.V., Onodera T., Prabhakar B.S., McClintock PR. Essani K., Ray U.R., Yagihashi S., Notkins A.L. 1983. Multiple organ-reactive monoclonal autoantibodies. Nature 304: 73-76.
38. 38. Lutton C.W., Gauntt C.J. 1986. Coxsackievirus B3 infection alters plasma membrane of neontal skin fibroblasts. J. Virol. 60: 294-296.
39. 39. Pujol-Borell R., Todd I., Doshi M., Bottazzo G.F., Sutton R., Gray D., Adolf G.R., Feldmann M. 1987. HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature 326: 304-306.
40. 40. Seery J.P. 1990. The link between viral infection and autoimmunity. Rev. Infect. Dis. 12: 1202.
41. 41. Shoenfeld Y., Schwartz R.S. 1984. Immunologic and genetic factors in autoimmune diseases. N. Engl. J. Med. 311: 1019-1029.
42. 42. Shoenfeld Y. 1994. Idiotypic induction of autoimmunity: a new saspect of the idiotypic network. FASEB J. 8: 1296-1301.
43. 43. Fried M., Conen D., Conzelmann M., Steinemann E. 1987. Uveitis after hepatitis B vaccination. Lancet 2: 631-632.
44. 44. Biasi D., Carletto A., Caramaschi P., Tonoli M., Bambara L.M. 1994. A case of reactive arthritis after influenza vaccination. Clin. Rheumatol. 13: 645.
45. 45. Cohen A.D., Shoenfeld Y. 1995. Goodpasture's syndrome as an autoimmune disease - Identification of the autoantigen (review). Harefuah 128: 100-104.
46. 46. Hjjorth R.N., Bonde G.M., Piner E., Hartzell R.W., Rorke L.B., Rubin B.A. 1984. Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. A possible model for Guillain-Barre syndrome. J. Neuroimmunol. 6: 1-8.
47. 47. Langmuir A.D., Bregman D.J., Kurland L.T., Nathanson N., Victor M. 1984. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Am. J. Epidemiol. 119: 841-879.
48. 48. Kinnunen E., Farkkila M., Hovi T., Juntunen J., Weckstrom A. 1989. Incidence of Guillain-Barre syndrome during a nationwide oral poliovirus vaccine campaign. Neurol. 39: 1034-1036.
49. 49. Chalmers A., Scheifele D., Patterson C., Williams D., Weber J., Shuckett R., Teufel A. 1994. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J. Rheumatol. 21: 1203-1206.
50. 50. Herron A., Dettleff G., Hixon B., Brandwin L., Ortals D., Hornick R., Hahn B. 1979. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 242: 53-56.
51. 51. Hess E.V., Hagn B. 1978. Influenza immunization in lupus erythematosus: Safe, Effective? Ann. Int. Med. 88: 833-834.
52. 52. Turner Stokes L., Cambridge G., Concoran T., Oxford J.S., Snaith M.L. 1988. In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. Ann. Rheum. Dis. 47: 532-535.
53. 54. Williams G.W., Steinberg A.D., Reinertsen J.L., Klassen L.W., Decker J.L., Dolin R. 1978. Influenza immunization in systemic lupus erythematosus. Ann. Intern. Med. 88: 729-734.
54. 55. Turner Stokes L., Isenberg D. 1988. Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheumatic Dis. 47: 529-531.
55. 56. Schattner A., Ben Chetrit E., Schmilovitz H. 1992. Poliovaccines and the course of systemic lupus erythematosus - a retrospective study of 73 patients. Vaccine 10: 98-100.
56. 57. Blumberg S., Bienfang D., Kantrowitz E.G. 1980. A possible association between influenza vaccination and small vessel vasculitis. Arch. Intern. Med. 80: 847-848.
57. 58. Vial T., Laine V., Delcombel M., Goubier C., Galland M.C., Mallaret M., Descotes J. 1990. Vasculitis after anti-influenza vaccination. Report of 5 cases. Therapie 45: 509-512.
58. 59. Helmke K., Otten A., Willems W.R., Brockhaus R., Mueller-Eckhardt G., Stief T., Bertrams J., Wolf H., Federlin K. 1986. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 29: 30-33.
59. 60. Hemachudha T., Griffin D.E., Giffels J.J., Johnson R.T., Moser-A.B., Phanuphak P. 1987. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N. Engl. J. Med. 316: 369-374.
60. 61. Poulin P., Gabriel B. 1994. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 344: 1293.
61. 62. Martinez E., Domingo P. 1992. Evan's syndrome triggered by recombinant hepatitis B vaccine. Clin. Inf. Dis. 15: 1051.
62. 63. Kurland L.T., Molgaard C.A., Kurland E.M., Wiederholt W.C., Kirkpatrick J.W. 1984. Swine flu vaccine and multiple sclerosis. JAMA 251: 2672-2675.